<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">METHOTRIMEPRAZINE</span><br/>(meth-oh-trye-mep'ra-zeen)<br/><span class="topboxtradename">Levoprome, </span><span class="topboxtradename">Nozinan <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">nonnarcotic analgesic</span>; <span class="classification">phenothiazine</span>; <span class="classification">anxiolytic</span>; <span class="classification">sedative-hypnotic</span><br/><b>Prototype: </b>Chlorpromazine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>20 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Tranquilizes and produces sedative effects; also has prominent analgesic properties. Extrapyramidal symptoms and dry mouth
         reportedly uncommon, but orthostatic hypotension and sedation effects are more prominent.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Raises pain threshold, produces amnesia, as well as sedative effects.</p>
<h1><a name="uses">Uses</a></h1>
<p>To relieve moderate to severe pain in nonambulatory patients and for analgesia and sedation when respiratory depression is
         to be avoided, as in obstetrics and pre- and postoperatively.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to phenothiazines and ingredients in the formulation (e.g., bisulfite); severe cardiac, kidney, or liver
         disease; history of convulsive disorders; significant hypotension; comatose states; premature labor; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Older adult and debilitated patients with heart disease; early pregnancy (category C), lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Analgesia, Sedation</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 1020 mg q46h<br/><br/><span class="indicationtitle">Preoperative Medication</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 220 mg 45 min3 h before surgery<br/><br/><span class="indicationtitle">Postoperative Analgesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 2.57.5 mg q46h as needed<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give IM injection deep into large muscle mass.</li>
<li>Pain at injection site and local inflammatory reaction commonly occur. Rotate injection sites and observe daily.</li>
<li>Mix in same syringe with either atropine or scopolamine, but not with any other drug. Reduce dosage of atropine or scopolamine.</li>
<li>Protect drug from light.</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle"></span><p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span> <b>Ranitidine.</b> <span class="incompattype">Y-site:</span> <b>Heparin.</b>
</p>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> CNS:</span> <span class="speceff-common">Excessive sedation, drowsiness, amnesia,</span> disorientation, euphoria, delirium, extrapyramidal symptoms, headache. <span class="typehead">CV:</span> <span class="speceff-common">Orthostatic hypotension with faintness,</span> weakness, dizziness; tachycardia, bradycardia, palpitation. <span class="typehead">Special Senses:</span> Blurred vision, nasal congestion. <span class="typehead">GI:</span> Nausea, vomiting, abdominal discomfort, dry mouth, jaundice. <span class="typehead">Urogenital:</span> Dysuria, hematuria. <span class="typehead">Body as a Whole:</span> Slurred speech, fever, chills, injection site reactions, increased weight. <span class="typehead">Respiratory:</span> <span class="speceff-life">Respiratory depression</span>. <span class="typehead">Hematologic:</span> Blood dyscrasias including <span class="speceff-life">agranulocytosis and pancytopenia</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol</b> and other <span class="classification">cns depressants</span> enhance CNS depression; with <span class="classification">anticholinergic agents</span>, aggravation of extrapyramidal symptoms, CNS stimulation, delirium, tachycardia, and hypotension; <span class="classification">antihypertensive agents</span>, <span class="classification">mao inhibitors</span> add to hypotensive effects; <b>epinephrine</b> may antagonize pressor effects; <span class="classification">skeletal muscle relaxants</span> may prolong duration of muscle relaxation.  
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead"> Onset:</span> 2040 min. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Duration:</span> 4 h. <span class="typehead">Distribution:</span> Crosses CSF and placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Slowly excreted in urine; elimination may continue for 1 wk after a single dose. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Carefully supervise ambulation for at least 6 h, but preferably 12 h. Orthostatic hypotension with faintness, weakness, and
            dizziness may occur within 1020 min after drug administration and may last 46 h and occasionally as long as 12
            h. Tolerance to effects usually develops with successive doses.
         </li>
<li>Excessive sedation and amnesia also occur commonly during early drug therapy.</li>
<li>Assess BP and pulse frequently until dosage requirements and response are stabilized. Monitor older adult and debilitated
            patients closely.
         </li>
<li>Methotrimeprazine injection contains a bisulfite, an allergen for some patients.</li>
<li>Do not treat severe hypotension with epinephrine; it is specifically contraindicated.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>